Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues...
Direct-to-consumer virtual care company Ro has acquired Dadi, a male fertility and sperm-testing startup.
The move comes less than a year after Ro scooped up another reproductive health-focused company, Modern Fertility.
As part of the deal, the virtual care company will retire the Dadi name and launch the Ro Sperm Kit, which allows users to collect samples at home for analysis and storage. The...
Men's fertility startup Legacy has landed $10 million in a Series A funding round led by FirstMark Capital.
As part of the deal, FirstMark Capital's Rick Heitzmann, who serves as the founder and managing partner, will be joining the company's Legacy Board.
In February of 2020, Legacy announced a $3.5 million seed funding round. This new infusion of cash brings the Boston-based company's total...
Legacy, a male fertility startup offering sperm freezing and analytics, has raised $3.5 million in a new funding round, CEO Khaled Kteily confirmed to MobiHealthNews. The funding was headlined by a “major” investment from Section 32, with Y Combinator and prior backer Bain Capital Ventures also lending their support.
WHAT THEY DO
Born out of the Harvard Innovation Labs alumni incubator program, ...
Brooklyn-based Dadi, a direct-to-consumer male fertility testing and sperm storage startup, has closed $5 million in investment funding. The raise was led by TCG, with participation from prior backers firstminute Capital and Third Kind Ventures. Additionally, Flatiron Health CEO and cofounder Nat Turner and GIPHY CEO and cofounder Alex Chung joined as new angel investors.
WHAT THEY DO
Launched in...
Sandstone Diagnostics has received FDA 510(k) clearance for its Trak system, an app-connected home test for male fertility. Trak's device aims to disrupt the current model for testing male fertility which is viewed by many as awkward and inconvenient. The device received over-the-counter clearance as a Class 2 medical device.
"This FDA clearance represents a monumental milestone for Sandstone...
Glow has announced that its fertility tracking app will now help men track and troubleshoot their fertility as well. Previously, women could add a partner account to their app for a man, but this account just helped the man support the woman who was tracking her fertility.
In the new update, a man can log his daily activities and enter lifestyle information into the app. Glow will then use this...
